 | Pharmaceutical Supply Chain: Drug Quality and Security Act Subjects: Economics Finance Business & Industry; Engineering & Technology; Politics & International Relations; Government; Business Management and Accounting; Engineering Management; Supply Chain Management; Public & Nonprofit Management; Error-proofing in the production process of pharmaceuticals isn't just a matter of good business, it has life-and-death implications for consumers. To that end, the 2013 Drug Quality and Security Act in large part requires new mandates on tracking and tracing chain of custody in the supply chain. Pharmaceutical Supply Chain: Drug Quality and Securi Karl F. Kuglin is a professional services consultant with Ernst & Young LLP in the EY Life Sciences industry group. He helps pharmaceutical companies to adapt and lead change to the industry, including emerging science, new products and services, shifting demographics, evolving regulations (such as the Drug Quality and Security Act), transforming business models, and increased stakeholder expectations. |
